Indications for Use: Optiflux F160NRe, F180NRe, F200NRe and F250NRe dialyzers are intended for patients with acute or chronic renal failure when conservative therapy is judged to be inadequate. Optiflux F16NRe, F18NRe and F180NR and Hemoflow F3 and F4 dialyzers are designed for single use in acute and chronic hemodialysis. The Hemoflow F40S is designed for single use in chronic hemodialysis or hemodiafiltration respectively.
Caution: Federal (US) law restricts these devices as the responsibility of the physician.
Note: Read the Instructions for Use for safe and proper use of these devices. For complete description of hazards, contraindications, side effects and precautions, see full package labeling available at www.fmcna.com.
Note: The applicability of a dialyzer for a particular treatment is the responsibility of the physician. In rare cases, thrombocytopenia, hypersensitivity reactions including anaphylactic or anaphylactic reactions to the dialyzer, or other elements in the extracorporeal circuit may occur during hemodialysis.
©2009-2017, Fresenius Medical Care, All Rights Reserved. Fresenius Medical Care, the triangle logo, Fresenius Renal Technologies, Fresenius Polysulfone, Hemoflow and Optiflux are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademark are the proper of their respective owners.
P/N 101595-01 Rev C 10/2017